These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6788984)

  • 1. [In vitro studies on the activities of cephalothin against selected bacteria (author's transl)].
    Masuda G; Yajima T; Nakamura K; Shimizu N; Tamagawa S
    Jpn J Antibiot; 1981 Feb; 34(2):194-9. PubMed ID: 6788984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of timed bacteriostatic and bactericidal activities of cephalothin against gram-positive and gram-negative bacteria.
    Masuda G; Negishi M; Young C
    Chemotherapy; 1982; 28(6):454-60. PubMed ID: 6761081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Timed bacteriostatic and bactericidal activities of cefmetazole against selected gram-negative bacteria].
    Masuda G; Young C; Negishi M; Watanabe T; Yamazaki E; Motegi K
    Jpn J Antibiot; 1982 Sep; 35(9):2288-92. PubMed ID: 6754988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriostatic and bactericidal activities of beta-lactam antibiotics enhanced by the addition of low concentrations of gentamicin.
    Masuda G; Nakamura K; Yajima T; Saku K
    Antimicrob Agents Chemother; 1980 Mar; 17(3):334-6. PubMed ID: 6775591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal activity of ertapenem against major intra-abdominal pathogens.
    Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S
    Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro activity of cefoxitin, a new cephalosporin (author's transl)].
    Shah PM; Zwischenbrugger H; Stille W
    MMW Munch Med Wochenschr; 1976 Nov; 118(45):1469-72. PubMed ID: 825763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of bacteriostatic and bactericidal drugs: lack of significant in vitro antagonism between penicillin, cephalothin, and rolitetracycline.
    Daschner FD
    Antimicrob Agents Chemother; 1976 Nov; 10(5):802-8. PubMed ID: 795370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.
    Skar AG; Midtvedt T; Dahl O
    NIPH Ann; 1979 Dec; 2(2):31-40. PubMed ID: 398460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro antibacterial activity of tobramycin used in combination with cephalothin or carbenicillin (author's transl)].
    Mayama M; Nagata H; Aoi I
    Jpn J Antibiot; 1978 Mar; 31(3):153-65. PubMed ID: 246946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the antibacterial activity of penicillins and cephalosporines in urine (author's transl)].
    Shah PM; Schirmer KP; Helm EB; Stille W
    Arzneimittelforschung; 1976; 26(9):1636-8. PubMed ID: 826261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The antibacterial activity of diphenhydramine (author's transl)].
    Semenitz E
    Wien Klin Wochenschr; 1978 Oct; 90(19):710-4. PubMed ID: 99881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tetracyclines: bacteriostatic or bactericidal drugs? In vitro studies with rolitetracycline, minocycline and doxycycline (author's transl)].
    Daschner F
    Zentralbl Bakteriol Orig A; 1977 Dec; 239(4):527-34. PubMed ID: 345688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro examination on antibacterial activities of broad-spectrum antibiotics against gram-negative clinical isolates (author's transl)].
    Deguchi K; Oda S; Sato Y; Ikeda Y; Nakamura T
    Jpn J Antibiot; 1975 Dec; 28(6):785-94. PubMed ID: 1104913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2002). III. Secular changes in susceptibility].
    Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Hirose T; Yamaguti O; Ishibashi K; Shigeta S; Suzutani T; Yoshida H; Imafuku Y; Murai M; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Sato S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Furuya N; Deguchi T; Ishihara S; Ooe H; Nishikawa M; Oka T; Kitamura M; Fukuhara Y; Kamidono S; Arakawa S; Kumon H; Monden K; Matsumoto T; Takahashi K; Naito S; Egashira T; Kohno S; Miyazaki Y; Hirakata Y; Aoki S
    Jpn J Antibiot; 2004 Aug; 57(4):311-403. PubMed ID: 15535040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical laboratory approach for estimating effective administrative dose of cephalothin. Reevaluation of MIC break points in 4 category system of disc susceptibility test].
    Uete T; Matsuo K
    Jpn J Antibiot; 1989 Sep; 42(9):1900-12. PubMed ID: 2810753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cephalothin on growth patterns of micro-organisms.
    Bodey GP; Pan T
    J Antibiot (Tokyo); 1976 Oct; 29(10):1092-5. PubMed ID: 792494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the antibacterial efficacy of doxycycline and tetracycline (author's transl)].
    Semenitz E; Lackner M
    Med Klin; 1977 Feb; Spec No():suppl 12-6. PubMed ID: 320436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
    McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
    J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.